On Tuesday, February 16th, learn the latest information on Decree 650 and changes in device guidance, regulations, and in-China clinical trials in a webinar presented by Brandwood Biomedical Director of China Operations, Steven Wen. Click here for your free...
The House Appropriations Committee announced the Omnibus Appropriations bill providing the FDA and NIH more funds in the coming year. FDA will receive more funding in 2016 for: medical product safety initiatives Combating Antibiotic Resistant Bacteria (CARB)...
Next Tuesday, learn about the emerging trends in Asia Pacific regulations in a webinar presented by Principal Consultant, Arthur Brandwood of Brandwood Biomedical. Click here for your FREE registration. Learn more about Brandwood Medical here.
Pearl Pathways is pleased to announce a global partnership with Brandwood Biomedical, an Australia-headquartered regulatory and quality services company with offices throughout Asia. This collaboration allows both companies to provide on-the-ground support to clients...
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?